Based on these findings, we attempt to quantitatively assess the association between the Arg72Pro (rs1042522) polymorphisms of the TP53 gene and T309G of the MDM2 gene with the susceptibility to developing bladder cancer. This evidence concerns the gene TP53 and urinary bladder carcinoma.